Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GeparSixto: Carboplatin in Neoadjuvant Breast Cancer
NCT01426880Phase 3Completed
- Sponsor
- GBG Forschungs
- Start
- Aug 2011
- Primary completion
- May 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in triple-negative breast cancer (TNBC), HER2-positive breast cancer, sponsored by GBG Forschungs. Started Aug 2011; status: completed.
02
Drugs
carboplatin
03
Conditions
triple-negative breast cancer (TNBC)HER2-positive breast cancer
Beyond the preview
Go deeper on NCT01426880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426880.